Acquisition Will Strengthen PROTEOR’s Expanding Digital Portfolio
DIJON, France, Feb. 5, 2025 /PRNewswire/ — PROTEOR today announced the acquisition of Filament Innovations, a leader in the design and manufacture of 3D printing solutions for the Orthotics & Prosthetics (O&P) industry. With this pivotal acquisition, PROTEOR further strengthens & expands its portfolio of Digital Solutions, which now includes scanning, rectification software, and 3D printing capabilities.
“By acquiring Filament Innovations, PROTEOR is able to offer the highest quality 3D printers in the industry while further elevating and streamlining the overall digital experience for our customers,” said Edouard Archambeaud, CEO of PROTEOR. “We are very excited to welcome Filament Innovations into the PROTEOR family.”
Filament Innovations is an industry leader in two key areas:
“We are committed to providing our customers with the most advanced 3D printing technologies available today – including the highest-quality filament available,” said Mike Gorski, CEO and founder of Filament Innovations. “The PROTEOR acquisition will enable our technologies and materials to reach more people in more places around the world. In this industry, I have learned a lot from our customers on how this process needs to be streamlined for widespread digital adoption. PROTEOR, especially with the ORTEN software, will soon allow us to connect all of our digital devices allowing for a streamlined digital workflow process, a critical process that is missing from the industry.”
To learn more about the PROTEOR Digital Portfolio, contact your PROTEOR representative or visit us.proteor.com.
THE PROTEOR PROMISE
PROTEOR is a leading prosthetic and orthotic device company committed to collaborating with clinicians to spark real-world innovations. We are inspired by the people who use our products. Seeing their everyday achievements motivate us to make more things possible. Our extensive portfolio includes technological breakthroughs that allow the utmost mobility, maneuverability, adaptability, and durability. PROTEOR’s process for developing advancements and community support is based on a collaborative approach with clinicians and the people they care for. When we all work together, it’s amazing how much patients can achieve. #HumanFirst
Media Contact:
Alexandra Houiste, Global Corporate Communications Manager
PROTEOR
+33 (0)6 40 73 99 97
Alexandra.Houiste@Proteor.com
Eric Ferris, Vice President – Global Marketing & Product Management
PROTEOR
+1.855.450.7300
Eric.Ferris@proteor.com
SOURCE PROTEOR
CLEVELAND, March 31, 2025 /PRNewswire/ -- GenomOncology, a precision medicine software company, today announced a…
PITTSBURGH, March 31, 2025 /PRNewswire/ -- "I thought there could be a way to improve…
FRISCO, Texas, March 31, 2025 /PRNewswire/ -- Petszel, the leading platform for post-adoption support, has…
Market Growth Driven by Government Initiatives, Technological Advancements, and Increasing Patient Preference for Outpatient Care…
HealthCheck360 Deploys TrampolineAI, Seeing Immediate Impact SAN FRANCISCO, March 31, 2025 /PRNewswire/ -- TrampolineAI, an AI-powered…
LAGUNA NIGUEL, Calif., March 31, 2025 /PRNewswire/ -- Alleva, a leading provider of behavioral health…